W. Higuchi

发表

Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study

K. Kishi, Y. Aizawa, M. Masuko, 2011, International journal of hematology.

Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation

F. Ushikubi, M. Okuma, A. Shibata, 1993 .

Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.

F. Ushikubi, M. Okuma, A. Shibata, 1993, Blood.

Hypereosinophilic syndrome terminating in acute myelogenous leukemia.

T. Koike, A. Shibata, W. Higuchi, 1993, Acta haematologica.

Mutations of the Platelet Thromboxane A2 (TXA2) Receptor in Patients Characterized by the Absence of TXA2–induced Platelet Aggregation despite Normal TXA2 Binding Activity

Y. Aizawa, I. Fuse, A. Hattori, 1999, Thrombosis and Haemostasis.

1‐deamino‐8‐d‐arginine vasopressin (ddavp) normalized the bleeding time in patients with platelet disorder characterized by defective calcium ionophore‐induced platelet aggregation

Y. Aizawa, I. Fuse, W. Higuchi, 2003, British Journal of Haematology.

DDAVP normalized the bleeding time in patients with congenital platelet TxA2 receptor abnormality

Y. Aizawa, I. Fuse, W. Higuchi, 2003, Transfusion.

Combined Ala601-Thr-type dysplasminogenaemia and antiphospholipid antibody syndrome in a patient with recurrent thrombosis.

S. Ito, F. Gejyo, S. Nishi, 2002, Thrombosis research.

Inhibitory mechanism of human platelet aggregation by nafamostat mesilate.

Y. Aizawa, K. Toba, I. Fuse, 1999, Platelets.

Antithrombin Niigata: A Novel Missense Mutation (Thrl94-lle) of the Antithrombin Gene Results in Type I Deficiency

Y. Aizawa, T. Ozawa, I. Fuse, 2000, Thrombosis and Haemostasis.

Pathogenesis of a Bleeding Disorder Characterized by Platelet Unresponsiveness to Thromboxane A2

Y. Aizawa, I. Fuse, W. Higuchi, 2000, Seminars in thrombosis and hemostasis.

Pathogenetic Analysis of Five Cases with a Platelet Disorder Characterized by the Absence of Thromboxane A2(TXA2)-Induced Platelet Aggregation in Spite of Normal TXA2 Binding Activity

Y. Aizawa, A. Shibata, K. Yahata, 1996, Thrombosis and Haemostasis.

Hematopoietic recovery in a patient with acute lymphoblastic leukemia after an autologous marrow graft purged by combined hyperthermia and interferon in vitro.

K. Kishi, A. Miura, T. Koike, 1991, Bone marrow transplantation.

Overproduction of Antiplatelet Antibody against Glycoprotein IIb after Splenectomy in a Patient with Evans Syndrome Resulting in Acquired Thrombasthenia

Y. Aizawa, Toru Watanabe, M. Narita, 1998, Acta Haematologica.

Difference in CD22 molecules in human B cells and basophils.

Kenichi Watanabe, Y. Aizawa, K. Toba, 2002, Experimental hematology.

Relationship between intracellular calcium-dependent process and protein-tyrosine phosphorylation in human platelets: studies of platelets from a patient with defective A23187-induced platelet aggregation.

Y. Aizawa, Y. Uesugi, I. Fuse, 1999, Clinical and laboratory haematology.

Pathogenetic analysis of three cases with a bleeding disorder characterized by defective platelet aggregation induced by Ca2+ ionophores

Y. Aizawa, Y. Uesugi, I. Fuse, 2001, British journal of haematology.

Arg60 Leu Mutation in the First Cytoplasmic Loop of the Platelet Thromboxane A2 Receptor Is Not Essential for Mediating Inhibitory Coupling between the Receptor and Adenylyl Cyclase

Y. Aizawa, I. Fuse, W. Higuchi, 2001, Acta Haematologica.